Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Retained Earnings

-$470.33M

Quarterly · Period ending: · USD

LCTX logo

LCTX Retained Earnings

Latest reported-$470.33M
LCTX Quarterly Retained Earnings (-$700.00K → -$470.33M)
High-resolution chart · PNG

LCTX retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-470,328,000
-471,810,000
-466,998,000
-467,849,000
-438,068,000
-407,604,000
-403,465,000
-400,192,000
-397,158,000
-391,398,000
-384,856,000
-380,081,000
-372,971,000
-367,742,000
-363,370,000
-357,016,000
-350,947,000
-344,184,000
-337,097,000
-308,105,000
-300,282,000
-295,494,000
-294,078,000
-296,103,000
-288,343,000
-281,821,000
-273,422,000
-268,940,000
-252,435,000
-222,403,000
-261,856,000
-216,905,000
-283,630,000
-279,416,000
-216,297,000
-144,363,000
-158,684,000
-147,033,000
-196,321,000
-190,534,000
-221,743,000
-246,293,000
-229,181,000
-215,757,000
-202,055,000
-192,357,575
-182,190,207
-171,606,642
-163,387,382
-153,877,561
-145,778,547
-126,166,233
-117,178,103
-109,614,976
-101,895,712
-95,860,758
-90,899,131
-85,443,351
-80,470,009
-75,109,358
-71,596,731
-67,316,641
-63,954,509
-60,984,987
-56,315,757
-54,056,655
-52,769,891
-54,190,078
-50,614,976
-49,143,606
-47,625,392
-46,060,432
-44,983,326
-44,320,547
-43,844,497
-43,517,703
-43,304,210
-42,960,135
-42,406,271
-42,027,718
-41,687,682
-41,019,839
-40,541,650
-40,051,780
-39,636,723
-39,193,989
-38,467,399
-37,919,345
-37,467,285
-37,025,017
-35,382,075
-34,783,982
-35,146,002
-34,391,130
-33,640,000
-32,863,522
-32,284,658
-31,501,477
-30,795,069
-30,111,374
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.